Table 1 Patient characteristics
| Â | N with complete data | N (Percentage) or Median (IQR) |
|---|---|---|
Female Gender | 126 | 76 (60.3%) |
African American Race | 126 | 14 (11.1%) |
Age (years) | 126 | 47 (35, 54) |
Height (cm) | 126 | 172.1 (164.5, 181.3) |
Weight (kg) | 126 | 80.4 (71.5, 91.7) |
BMI (kg/m2) | 126 | 26.8 (24.4, 30.3) |
TKV (cc) | 114 | 1792 (984, 2713) |
Hemoglobin (g/dL) | 124 | 13 (12, 14) |
Urine Alb/Cr ratio (mg/g) | 123 | 19.8 (11.3, 36.4) |
eGFR (ml/min/1.73m2) | 126 | 63 (43, 90) |
Systolic BP (mmHg) | 126 | 125 (116, 133) |
Diastolic BP (mmHg) | 126 | 78 (71, 84) |
Heart Rate (/min) | 126 | 62 (54, 68) |
Irazabal ADPKD Class | ||
 1A & 1B | 114 | 24 (21.1%) |
 1C | 114 | 38 (33.3%) |
 1D | 114 | 30 (26.3%) |
 1E | 114 | 22 (19.3%) |
LVM (g) | ||
 Male | 50 | 179 (144, 205) |
 Female | 76 | 140 (113, 172) |
 Both | 126 | 159 (123, 187) |
LVMI (g/m2) | ||
 Male | 50 | 85 (71, 97) |
 Female | 76 | 79 (64, 87) |
 Both | 126 | 81 (67, 92) |
HTN Medications | ||
 ACEI/ARB | 126 | 80 (63.5%) |
 Diuretic | 126 | 13 (10.3%) |
 Other Anti HTN Drug | 126 | 31 (24.6%) |
Medical History | ||
 Hx of HTN | 126 | 98 (77.8%) |
 Age of HTN Onset | 126 | 35 (27, 46) |
 Duration of HTN | 126 | 8 (1, 6) |
 Medical Hx of CVD | 126 | 21 (16.7%) |
 Family Hx of CVD | 126 | 61 (48.4%) |